Free Trial

Novogen (KZIA) Short Interest Ratio & Short Volume

Novogen logo
$6.78 +0.22 (+3.35%)
Closing price 03:58 PM Eastern
Extended Trading
$6.74 -0.04 (-0.65%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novogen Short Interest Data

Novogen (KZIA) has a short interest of 48,500 shares. This marks a 297.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 515,308 shares to cover all short positions.

Current Short Interest
48,500 shares
Previous Short Interest
12,200 shares
Change Vs. Previous Month
+297.54%
Dollar Volume Sold Short
$387.52 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
September 15, 2025
Outstanding Shares
1,010,000 shares
Percentage of Shares Shorted
4.80%
Today's Trading Volume
44,116 shares
Average Trading Volume
515,308 shares
Today's Volume Vs. Average
9%
Short Selling Novogen?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Novogen and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

KZIA Short Interest Over Time

KZIA Days to Cover Over Time

KZIA Percentage of Float Shorted Over Time

Novogen Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202548,500 shares $387.52 thousand +297.5%N/A0.2 $7.99
8/31/202512,200 shares $98.10 thousand -63.5%1.2%0 $8.04
8/15/202533,400 shares $268.20 thousand +7.4%N/A0 $8.03
7/31/202531,100 shares $260.62 thousand -31.2%3.1%0 $8.38
7/15/202545,200 shares $488.16 thousand +151.1%N/A0 $10.80
6/30/202518,000 shares $112.86 thousand -90.8%1.8%0 $6.27
6/15/2025196,000 shares $1.82 million +1,261.1%19.7%0.2 $9.30
5/31/202514,400 shares $54.43 thousand -28.0%0.3%0.5 $3.78
5/15/202520,000 shares $68 thousand +4.2%0.4%0.5 $3.40
4/30/202519,200 shares $68.93 thousand +44.4%N/A0.4 $3.59
4/15/202513,300 shares $48.22 thousand -83.6%0.3%0 $3.63
3/31/202581,200 shares $63.57 thousand -29.9%1.6%0 $0.78
3/15/2025115,900 shares $115.34 thousand +94.5%2.3%0.1 $1.00
2/28/202559,600 shares $50.74 thousand -34.1%2.1%0 $0.85
2/15/202590,500 shares $80.55 thousand -90.2%3.1%0.1 $0.89
1/31/2025921,900 shares $1.46 million +7,712.7%31.7%0.5 $1.58
1/15/202511,800 shares $18.29 thousand +110.7%0.4%0.1 $1.55
12/31/20245,600 shares $9.91 thousand -66.7%N/A0 $1.77
12/15/202416,800 shares $59.64 thousand -24.7%N/A0.1 $3.55
11/30/202422,300 shares $115.29 thousand -36.3%N/A0.2 $5.17
11/15/202435,000 shares $159.95 thousand +86.2%N/A0.2 $4.57
10/31/202418,800 shares $101.52 thousand -88.5%N/A0.1 $5.40
10/15/2024164,000 shares $54.14 thousand -47.4%N/A0.1 $0.33
9/30/2024311,600 shares $133.96 thousand -80.5%N/A0 $0.43
9/15/20241,600,000 shares $548.96 thousand +388.1%N/A0.1 $0.34
8/31/2024327,800 shares $138.76 thousand -21.8%N/A0 $0.42
8/15/2024418,900 shares $161.28 thousand +85.0%N/A0 $0.39
7/31/2024226,400 shares $84.45 thousand -93.3%N/A0 $0.37
7/15/20243,380,000 shares $1.89 million +7,076.2%N/A0.3 $0.56
6/30/202447,100 shares $10.77 thousand +97.9%N/A0 $0.23
6/15/202423,800 shares $5.48 thousand -10.2%N/A0.1 $0.23
5/31/202426,500 shares $6.89 thousand -45.0%N/A0.1 $0.26
5/15/202448,200 shares $13.01 thousand -44.0%N/A0.1 $0.27
4/30/202486,000 shares $28.79 thousand +367.4%N/A0.1 $0.33
4/15/202418,400 shares $5.65 thousand -92.9%N/A0 $0.31
3/31/2024259,500 shares $80.39 thousand +6.9%N/A0.3 $0.31
3/15/2024242,800 shares $54.36 thousand -68.3%N/A0.3 $0.22
2/29/2024765,100 shares $195.18 thousand +1,566.9%N/A1.1 $0.26
2/15/202445,900 shares $14.24 thousand -74.7%N/A0.1 $0.31
1/31/2024181,700 shares $54.33 thousand +54.5%N/A1 $0.30
1/15/2024117,600 shares $41.15 thousand +103.1%N/A1.1 $0.35
12/31/202357,900 shares $25.45 thousand +32.8%N/A0.6 $0.44
12/15/202343,600 shares $17.05 thousand -40.3%N/A0.5 $0.39
11/30/202373,000 shares $40.93 thousand -35.6%N/A0.9 $0.56
11/15/2023113,400 shares $87.66 thousand +1,889.5%N/A1.6 $0.77
10/31/20235,700 shares $2.39 thousand -95.0%N/A0.1 $0.42
10/15/2023113,800 shares $77.38 thousand +116.8%N/A3.1 $0.68
9/30/202352,500 shares $52.25 thousand +10.3%N/A1.3 $1.00
9/15/202347,600 shares $48.08 thousand -24.3%N/A0.3 $1.01
8/31/202362,900 shares $57.25 thousand +10.5%N/A0.3 $0.91
8/15/202356,900 shares $51.33 thousand -33.5%N/A0.3 $0.90
7/31/202385,600 shares $86.46 thousand -2.5%N/A0.5 $1.01
7/15/202387,800 shares $76.75 thousand -36.8%N/A0.5 $0.87
6/30/2023139,000 shares $158.46 thousand -3.6%N/A0.8 $1.14
6/15/2023144,200 shares $181.69 thousand -10.7%N/A4.7 $1.26
5/31/2023161,500 shares $192.19 thousand +20.3%N/A4.8 $1.19
5/15/2023134,300 shares $178.62 thousand -24.4%N/A3 $1.33
4/30/2023177,700 shares $236.34 thousand +28.2%N/A3.9 $1.33
4/15/2023138,600 shares $182.95 thousand -2.0%N/A2.8 $1.32
3/31/2023141,400 shares $145.66 thousand +10.0%N/A2.7 $1.03
3/15/2023128,600 shares $120.77 thousand -8.5%N/A2.2 $0.94
2/28/2023140,600 shares $129.35 thousand -3.8%N/A2.3 $0.92
2/15/2023146,100 shares $131.49 thousand -17.3%N/A2.6 $0.90
1/31/2023176,700 shares $182.00 thousand -28.5%N/A2.8 $1.03
1/15/2023247,100 shares $259.46 thousand +64.2%N/A0.7 $1.05
12/30/2022150,500 shares $92.54 thousand -7.8%N/A0.4 $0.61
12/15/2022163,300 shares $89.15 thousand -6.1%N/A0.5 $0.55
11/30/2022173,900 shares $104.97 thousand -3.4%N/A0.5 $0.60
11/15/2022180,100 shares $118.87 thousand -75.8%N/A0.5 $0.66
10/31/2022744,000 shares $614.77 thousand +526.3%N/A2.1 $0.83
10/15/2022118,800 shares $118.80 thousand +7.1%N/A0.4 $1.00
9/30/2022110,900 shares $121.99 thousand -5.9%N/A0.4 $1.10
9/15/2022117,900 shares $168.60 thousand -20.7%N/A0.3 $1.43
8/31/2022148,700 shares $227.51 thousand -24.8%N/A0.2 $1.53
8/15/2022197,700 shares $345.98 thousand +68.7%N/A0.3 $1.75
7/31/2022117,200 shares $425.44 thousand -19.0%N/A0.2 $3.63
7/15/2022144,600 shares $539.36 thousand +113.9%N/A0.4 $3.73
6/30/202267,600 shares $283.92 thousand +90.4%N/A0.2 $4.20
6/15/202235,500 shares $191.70 thousand +86.8%N/A0.1 $5.40
5/31/202219,000 shares $110.01 thousand -21.2%N/A0.7 $5.79
5/15/202224,100 shares $132.31 thousand +225.7%N/A1.2 $5.49
4/30/20227,400 shares $47.58 thousand -53.5%N/A0.5 $6.43
4/15/202215,900 shares $121.32 thousand +45.9%N/A1.2 $7.63
3/31/202210,900 shares $84.04 thousand +445.0%N/A0.7 $7.71
3/15/20222,000 shares $12.10 thousand -79.4%N/A0.1 $6.05
2/28/20229,700 shares $65.18 thousand +592.9%N/A0.5 $6.72
2/15/20221,400 shares $10.51 thousand +55.6%N/A0.1 $7.51
1/31/2022900 shares $6.03 thousand -64.0%N/A0 $6.70
1/15/20222,500 shares $19.50 thousand -19.4%N/A0.1 $7.80
12/31/20213,100 shares $26.10 thousand -59.2%N/A0.1 $8.42
12/15/20217,600 shares $55.86 thousand +20.6%N/A0.3 $7.35
11/30/20216,300 shares $63.19 thousand +162.5%N/A0.2 $10.03
11/15/20212,400 shares $26.86 thousand +4.4%N/A0.1 $11.19
10/29/20212,300 shares $24.91 thousand -37.8%N/A0.1 $10.83
10/15/20213,700 shares $38.85 thousand -67.8%N/A0.1 $10.50
9/30/202111,500 shares $130.18 thousand -27.7%N/A0.5 $11.32
9/15/202115,900 shares $165.04 thousand -29.0%N/A0.6 $10.38
8/31/202122,400 shares $243.04 thousand +21.7%N/A0.7 $10.85
8/13/202118,400 shares $174.80 thousand -18.6%N/A0.6 $9.50
7/30/202122,600 shares $204.08 thousand -3.0%N/A0.6 $9.03
7/15/202123,300 shares $223.21 thousand -16.5%N/A0.6 $9.58
6/30/202127,900 shares $275.09 thousand +57.6%N/A0.5 $9.86
6/15/202117,700 shares $189.92 thousand -18.1%N/A0.2 $10.73
5/28/202121,600 shares $205.42 thousand -14.3%N/A0.2 $9.51
5/14/202125,200 shares $239.90 thousand -38.2%N/A0.2 $9.52
4/30/202140,800 shares $444.72 thousand +1,175.0%N/A0.3 $10.90
4/15/20213,200 shares $36.54 thousand -88.5%N/A0 $11.42
3/31/202127,700 shares $333.51 thousand -27.1%N/A0.2 $12.04
3/15/202138,000 shares $417.24 thousand +32.9%N/A0.3 $10.98
2/26/202128,600 shares $297.15 thousand +236.5%N/A0.2 $10.39
2/12/20218,500 shares $85.85 thousand -18.3%N/A0 $10.10
1/29/202110,400 shares $99.42 thousand -35.0%N/A0 $9.56
1/15/202116,000 shares $164.64 thousand No ChangeN/A0 $10.29

KZIA Short Interest - Frequently Asked Questions

What is Novogen's current short interest?

Short interest is the volume of Novogen shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 48,500 shares of KZIA short. Learn More on Novogen's current short interest.

Is Novogen's short interest increasing or decreasing?

Novogen saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 48,500 shares, an increase of 297.5% from the previous total of 12,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Novogen's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Novogen: Klotho Neurosciences, Inc. (4.84%), Dare Bioscience, Inc. (1.85%), Cadrenal Therapeutics, Inc. (0.84%), Kezar Life Sciences, Inc. (12.21%), Rein Therapeutics Inc. (0.10%), MIRA Pharmaceuticals, Inc. (1.37%), Passage Bio, Inc. (2.74%), Exicure, Inc. (1.84%), Moleculin Biotech, Inc. (8.50%), Enlivex Therapeutics Ltd. (1.28%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

What does it mean to sell short Novogen stock?

Short selling KZIA is an investing strategy that aims to generate trading profit from Novogen as its price is falling. KZIA shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Novogen?

A short squeeze for Novogen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KZIA, which in turn drives the price of the stock up even further.

How often is Novogen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZIA, twice per month. The most recent reporting period available is September, 15 2025.




This page (NASDAQ:KZIA) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners